Skip to main content
Top
Published in: Radiation Oncology 1/2010

Open Access 01-12-2010 | Research

Independent position correction on tumor and lymph nodes; consequences for bladder cancer irradiation with two combined IMRT plans

Authors: Dominique C van Rooijen, René Pool, Jeroen B van de Kamer, Maarten CCM Hulshof, Caro CE Koning, Arjan Bel

Published in: Radiation Oncology | Issue 1/2010

Login to get access

Abstract

Background

The application of lipiodol injections as markers around bladder tumors combined with the use of CBCT for image guidance enables daily on-line position correction based on the position of the bladder tumor. However, this might introduce the risk of underdosing the pelvic lymph nodes. In this study several correction strategies were compared.

Methods

For this study set-up errors and tumor displacements for ten complete treatments were generated; both were based on the data of 10 bladder cancer patients. Besides, two IMRT plans were made for 20 patients, one for the elective field and a boost plan for the tumor. For each patient 10 complete treatments were simulated. For each treatment the dose was calculated without position correction (option 1), correction on bony anatomy (option 2), on tumor only (option 3) and separately on bone for the elective field (option 4). For each method we analyzed the D99% for the tumor, bladder and lymph nodes and the V95% for the small intestines, rectum, healthy part of the bladder and femoral heads.

Results

CTV coverage was significantly lower with options 1 and 2. With option 3 the tumor coverage was not significantly different from the treatment plan. The ΔD99% (D99%, option n - D99%, treatment plan) for option 4 was small, but significant. For the lymph nodes the results from option 1 differed not significantly from the treatment plan. The median ΔD99% of the other options were small, but significant. ΔD99% for PTVbladder was small for options 1, 2 and 4, but decreased up to -8.5 Gy when option 3 was applied. Option 4 is the only method where the difference with the treatment plan never exceeds 2 Gy. The V95% for the rectum, femoral heads and small intestines was small in the treatment plan and this remained so after applying the correction options, indicating that no additional hot spots occurred.

Conclusions

Applying independent position correction on bone for the elective field and on tumor for the boost separately gives on average the best target coverage, without introducing additional hot spots in the healthy tissue.
Appendix
Available only for authorised users
Literature
1.
go back to reference Pos FJ, van Tienhoven G, Hulshof MC, Koedooder K, Gonzalez Gonzalez D: Concomitant boost radiotherapy for muscle invasive bladder cancer. Radiother Oncol 2003, 68: 75-80. 10.1016/S0167-8140(03)00019-7CrossRefPubMed Pos FJ, van Tienhoven G, Hulshof MC, Koedooder K, Gonzalez Gonzalez D: Concomitant boost radiotherapy for muscle invasive bladder cancer. Radiother Oncol 2003, 68: 75-80. 10.1016/S0167-8140(03)00019-7CrossRefPubMed
2.
go back to reference Piet AH, Hulshof MC, Pieters BR, Pos FJ, de Reijke TM, Koning CC: Clinical results of a concomitant boost radiotherapy technique for muscle-invasive bladder cancer. Strahlenther Onkol 2008, 184: 313-318. 10.1007/s00066-008-1797-3CrossRefPubMed Piet AH, Hulshof MC, Pieters BR, Pos FJ, de Reijke TM, Koning CC: Clinical results of a concomitant boost radiotherapy technique for muscle-invasive bladder cancer. Strahlenther Onkol 2008, 184: 313-318. 10.1007/s00066-008-1797-3CrossRefPubMed
3.
go back to reference Fokdal L, Honore H, Hoyer M, Meldgaard P, Fode K, von der Maase H: Impact of changes in bladder and rectal filling volume on organ motion and dose distribution of the bladder in radiotherapy for urinary bladder cancer. Int J Radiat Oncol Biol Phys 2004, 59: 436-444. 10.1016/j.ijrobp.2003.10.039CrossRefPubMed Fokdal L, Honore H, Hoyer M, Meldgaard P, Fode K, von der Maase H: Impact of changes in bladder and rectal filling volume on organ motion and dose distribution of the bladder in radiotherapy for urinary bladder cancer. Int J Radiat Oncol Biol Phys 2004, 59: 436-444. 10.1016/j.ijrobp.2003.10.039CrossRefPubMed
4.
go back to reference Lotz HT, Pos FJ, Hulshof MC, van Herk M, Lebesque JV, Duppen JC, Remeijer P: Tumor motion and deformation during external radiotherapy of bladder cancer. Int J Radiat Oncol Biol Phys 2006, 64: 1551-1558. 10.1016/j.ijrobp.2005.12.025CrossRefPubMed Lotz HT, Pos FJ, Hulshof MC, van Herk M, Lebesque JV, Duppen JC, Remeijer P: Tumor motion and deformation during external radiotherapy of bladder cancer. Int J Radiat Oncol Biol Phys 2006, 64: 1551-1558. 10.1016/j.ijrobp.2005.12.025CrossRefPubMed
5.
go back to reference Meijer GJ, Rasch C, Remeijer P, Lebesque JV: Three-dimensional analysis of delineation errors, setup errors, and organ motion during radiotherapy of bladder cancer. Int J Radiat Oncol Biol Phys 2003, 55: 1277-1287. 10.1016/S0360-3016(02)04162-7CrossRefPubMed Meijer GJ, Rasch C, Remeijer P, Lebesque JV: Three-dimensional analysis of delineation errors, setup errors, and organ motion during radiotherapy of bladder cancer. Int J Radiat Oncol Biol Phys 2003, 55: 1277-1287. 10.1016/S0360-3016(02)04162-7CrossRefPubMed
6.
go back to reference Miralbell R, Nouet P, Rouzaud M, Bardina A, Hejira N, Schneider D: Radiotherapy of bladder cancer: relevance of bladder volume changes in planning boost treatment. Int J Radiat Oncol Biol Phys 1998, 41: 741-746. 10.1016/S0360-3016(98)00131-XCrossRefPubMed Miralbell R, Nouet P, Rouzaud M, Bardina A, Hejira N, Schneider D: Radiotherapy of bladder cancer: relevance of bladder volume changes in planning boost treatment. Int J Radiat Oncol Biol Phys 1998, 41: 741-746. 10.1016/S0360-3016(98)00131-XCrossRefPubMed
7.
go back to reference Muren LP, Smaaland R, Dahl O: Organ motion, set-up variation and treatment margins in radical radiotherapy of urinary bladder cancer. Radiother Oncol 2003, 69: 291-304. 10.1016/S0167-8140(03)00246-9CrossRefPubMed Muren LP, Smaaland R, Dahl O: Organ motion, set-up variation and treatment margins in radical radiotherapy of urinary bladder cancer. Radiother Oncol 2003, 69: 291-304. 10.1016/S0167-8140(03)00246-9CrossRefPubMed
8.
go back to reference Pos FJ, Koedooder K, Hulshof MC, van Tienhoven G, Gonzalez Gonzalez D: Influence of bladder and rectal volume on spatial variability of a bladder tumor during radical radiotherapy. Int J Radiat Oncol Biol Phys 2003, 55: 835-841. 10.1016/S0360-3016(02)04158-5CrossRefPubMed Pos FJ, Koedooder K, Hulshof MC, van Tienhoven G, Gonzalez Gonzalez D: Influence of bladder and rectal volume on spatial variability of a bladder tumor during radical radiotherapy. Int J Radiat Oncol Biol Phys 2003, 55: 835-841. 10.1016/S0360-3016(02)04158-5CrossRefPubMed
9.
go back to reference Hsu A, Pawlicki T, Luxton G, Hara W, King CR: A study of image-guided intensity-modulated radiotherapy with fiducials for localized prostate cancer including pelvic lymph nodes. Int J Radiat Oncol Biol Phys 2007, 68: 898-902. 10.1016/j.ijrobp.2007.02.030CrossRefPubMed Hsu A, Pawlicki T, Luxton G, Hara W, King CR: A study of image-guided intensity-modulated radiotherapy with fiducials for localized prostate cancer including pelvic lymph nodes. Int J Radiat Oncol Biol Phys 2007, 68: 898-902. 10.1016/j.ijrobp.2007.02.030CrossRefPubMed
10.
go back to reference Ludlum E, Mu G, Weinberg V, Roach M III, Verhey LJ, Xia P: An algorithm for shifting MLC shapes to adjust for daily prostate movement during concurrent treatment with pelvic lymph nodes. Med Phys 2007, 34: 4750-4756. 10.1118/1.2804579CrossRefPubMed Ludlum E, Mu G, Weinberg V, Roach M III, Verhey LJ, Xia P: An algorithm for shifting MLC shapes to adjust for daily prostate movement during concurrent treatment with pelvic lymph nodes. Med Phys 2007, 34: 4750-4756. 10.1118/1.2804579CrossRefPubMed
11.
go back to reference Rossi PJ, Schreibmann E, Jani AB, Master VA, Johnstone PA: Boost first, eliminate systematic error, and individualize CTV to PTV margin when treating lymph nodes in high-risk prostate cancer. Radiother Oncol 2009, 90: 353-358. 10.1016/j.radonc.2008.09.021CrossRefPubMed Rossi PJ, Schreibmann E, Jani AB, Master VA, Johnstone PA: Boost first, eliminate systematic error, and individualize CTV to PTV margin when treating lymph nodes in high-risk prostate cancer. Radiother Oncol 2009, 90: 353-358. 10.1016/j.radonc.2008.09.021CrossRefPubMed
12.
go back to reference Pos F, Bex A, Dees-Ribbers HM, Betgen A, van Herk M, Remeijer P: Lipiodol injection for target volume delineation and image guidance during radiotherapy for bladder cancer. Radiother Oncol 2009, 93: 364-367. 10.1016/j.radonc.2009.09.003CrossRefPubMed Pos F, Bex A, Dees-Ribbers HM, Betgen A, van Herk M, Remeijer P: Lipiodol injection for target volume delineation and image guidance during radiotherapy for bladder cancer. Radiother Oncol 2009, 93: 364-367. 10.1016/j.radonc.2009.09.003CrossRefPubMed
13.
go back to reference Pos FJ, Hulshof MC, Lebesque JV, Lotz HT, van Tienhoven G, Moonen L, Remeijer P: Adaptive radiotherapy for invasive bladder cancer: a feasibility study. Int J Radiat Oncol Biol Phys 2006, 64: 862-868. 10.1016/j.ijrobp.2005.07.976CrossRefPubMed Pos FJ, Hulshof MC, Lebesque JV, Lotz HT, van Tienhoven G, Moonen L, Remeijer P: Adaptive radiotherapy for invasive bladder cancer: a feasibility study. Int J Radiat Oncol Biol Phys 2006, 64: 862-868. 10.1016/j.ijrobp.2005.07.976CrossRefPubMed
14.
go back to reference van Rooijen DC, van de Kamer JB, Pool R, Hulshof MC, Koning CC, Bel A: The effect of on-line position correction on the dose distribution in focal radiotherapy for bladder cancer. Radiation Oncology 2009, 4: 38. 10.1186/1748-717X-4-38PubMedCentralCrossRefPubMed van Rooijen DC, van de Kamer JB, Pool R, Hulshof MC, Koning CC, Bel A: The effect of on-line position correction on the dose distribution in focal radiotherapy for bladder cancer. Radiation Oncology 2009, 4: 38. 10.1186/1748-717X-4-38PubMedCentralCrossRefPubMed
15.
go back to reference Chai X, van Herk M, van de Kamer JB, Remeijer P, Bex A, Betgen A, de Reijke TM, Hulshof MC, Pos FJ, Bel A: Behavior of lipiodol markers during image guided radiotherapy of bladder cancer. Int J Radiat Oncol Biol Phys 2010, 77: 309-314. 10.1016/j.ijrobp.2009.08.019CrossRefPubMed Chai X, van Herk M, van de Kamer JB, Remeijer P, Bex A, Betgen A, de Reijke TM, Hulshof MC, Pos FJ, Bel A: Behavior of lipiodol markers during image guided radiotherapy of bladder cancer. Int J Radiat Oncol Biol Phys 2010, 77: 309-314. 10.1016/j.ijrobp.2009.08.019CrossRefPubMed
16.
go back to reference Bel A, van Rooijen DC, Kamphuis M, Pool R: APlan: A 4D treatment planning evaluation program. Radiother Oncol 2008, 88: S365. Bel A, van Rooijen DC, Kamphuis M, Pool R: APlan: A 4D treatment planning evaluation program. Radiother Oncol 2008, 88: S365.
17.
go back to reference de Greef M, Crezee J, van Eijk JC, Pool R, Bel A: Accelerated ray-tracing for radiotherapy dose calculations on a GPU. Med Phys 2009, 36: 4095-4102. 10.1118/1.3190156CrossRefPubMed de Greef M, Crezee J, van Eijk JC, Pool R, Bel A: Accelerated ray-tracing for radiotherapy dose calculations on a GPU. Med Phys 2009, 36: 4095-4102. 10.1118/1.3190156CrossRefPubMed
Metadata
Title
Independent position correction on tumor and lymph nodes; consequences for bladder cancer irradiation with two combined IMRT plans
Authors
Dominique C van Rooijen
René Pool
Jeroen B van de Kamer
Maarten CCM Hulshof
Caro CE Koning
Arjan Bel
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Radiation Oncology / Issue 1/2010
Electronic ISSN: 1748-717X
DOI
https://doi.org/10.1186/1748-717X-5-53

Other articles of this Issue 1/2010

Radiation Oncology 1/2010 Go to the issue